Adial Pharmaceuticals Inc
(ADIL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,591 | -11,631 | -1,140 | -420 | N/A |
| Depreciation Amortization | 1 | 353 | 103 | 1 | N/A |
| Other Working Capital | 208 | -849 | 336 | -8 | N/A |
| Other Operating Activity | 2,044 | 9,629 | 205 | 154 | 0 |
| Operating Cash Flow | $-6,339 | $-2,498 | $-495 | $-274 | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 35 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $35 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -335 | 350 | 200 | N/A |
| Common Stock Issued | 9,247 | 6,424 | 40 | N/A | N/A |
| Other Financing Activity | 0 | 260 | 0 | 0 | 0 |
| Financing Cash Flow | $9,247 | $6,349 | $390 | $200 | $N/A |
| Beginning Cash Position | 3,869 | 18 | 88 | 162 | N/A |
| End Cash Position | 6,777 | 3,869 | 18 | 88 | N/A |
| Net Cash Flow | $2,908 | $3,851 | $-70 | $-74 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,339 | -2,498 | -495 | -274 | N/A |
| Free Cash Flow | -6,339 | -2,498 | -495 | -274 | 0 |